Online Screening and Virtual Patient Education for Hereditary Cancer Risk Assessment and Testing.

Objective: To use online screening and virtual patient education tools to improve the provision of hereditary cancer risk assessment.

Methods: We conducted a prospective, single-arm study in which clinicians at five U.S.

The Patient Experience and Safety.

Patient harm continues to be a leading cause of morbidity and mortality in the United States. Among high-risk industries, the health care system has a significantly lower safety profile than that of others. There are many driving forces behind this, including significant resistance within the medical community in the late 1960s to consumer demand of patient-centered and family-centered care.

Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting.

Objective: To evaluate the feasibility and results of incorporating routine hereditary cancer risk assessment, counseling, and follow-up genetic testing in the community obstetrics and gynecology practice setting without referral to a genetic counselor.

Methods: This prospective process intervention study was conducted with two obstetrics and gynecology practice groups (five sites). The intervention included baseline process assessment, refinement of clinic-specific patient screening workflows and tools, and training in hereditary cancer risk screening and follow-up.

Collaboration in maternity care: possibilities and challenges.

The United States is about to face a maternity workforce crisis in the next decade because the number of medical students choosing obstetrics and gynecology is stagnant, the number of patients requiring care is increasing and many in the current workforce of obstetricians/gynecologists and midwives are ready to retire. There are not enough maternity providers to meet the future needs of women. Creative strategies must be explored to address these concerns.

A proposed model for managing cases of neurologically impaired infants.

The current mechanism for obtaining financial support for families with neurologically impaired infants is seriously flawed. It relies on payment awarded through the tort system based on a claim that medical negligence was responsible for the infant's condition. The system is extraordinarily inefficient and expensive, as well as being unfair to many families with affected children and to physicians who are unjustly accused of contributing to outcomes they could not have prevented.